Chemokines in eosinophil-associated gastrointestinal disorders

被引：21

作者：

Hogan, SP ^{[1
]}

Rothenberg, ME ^{[1
]}

Forbes, E ^{[1
]}

Smart, VE ^{[1
]}

Matthaei, KI ^{[1
]}

Foster, PS ^{[1
]}

机构：

[1] Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 0200, Australia

来源：

CURRENT ALLERGY AND ASTHMA REPORTS | 2004年 / 4卷 / 01期

关键词：

D O I：

10.1007/s11882-004-0047-8

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Eosinophil-associated gastrointestinal disorders (EGDs) are characterized by a pronounced cellular inflammation. Recent clinical and experimental investigations have implicated a family of molecules known as chemokines in the regulation of leukocyte, recruitment in these diseases. The underlying cellular and molecular mechanisms involved in chemokine-mediated cellular infiltration are largely unknown. In this review, we describe the role of CD4+ T cells and eosinophils in the clinical manifestations of EGDs and discuss the current understanding of the role of chemokines in the recruitment of these cells in the expression of diseases.

引用

页码：74 / 82

页数：9

共 50 条

[21] Online Education Yields Significant Gains in Physicians' Knowledge of Eosinophil-Associated Disorders
Stan, Adriana
Griffith, Gillian
Vandenbroucque, Juliette
Bachert, Claus
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB195 - AB195
[22] Eosinophils and eosinophil-associated cytokines in allergic inflammation
Kay, AB
Barata, L
Meng, Q
Durham, SR
Ying, S
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 113 (1-3) : 196 - 199
[23] Eosinophil-associated Ribonuclease 11 Is a Macrophage Chemoattractant
Yamada, Kelsey J.
Barker, Tolga
Dyer, Kimberly D.
Rice, Tyler A.
Percopo, Caroline M.
Garcia-Crespo, Katia E.
Cho, Soochin
Lee, James J.
Druey, Kirk M.
Rosenberg, Helene F.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (14) : 8863 - 8875
[24] Improving Care in Eosinophil-Associated Diseases: A Charter
David J. Jackson
Praveen Akuthota
Rebeca Andradas
Albert J. Bredenoord
Amanda Cordell
Sarah Gray
Joyce Kullman
Sameer K. Mathur
Ian Pavord
Florence Roufosse
Christian Rubio
Irena Clisson Rusek
Dagmar Simon
Mary Jo Strobel
Tonya Winders
Advances in Therapy, 2022, 39 : 2323 - 2341
[25] Cardiopulmonary and Gastrointestinal Manifestations of Eosinophil-associated Diseases and Idiopathic Hypereosinophilic Syndromes: Multimodality Imaging Approach
Katre, Rashmi S.
Sunnapwar, Abhijit
Restrepo, Carlos S.
Katabathina, Venkata S.
Mumbower, Amy
Baxi, Ameya
Sonavane, Sushilkumar
RADIOGRAPHICS, 2016, 36 (02) : 433 - 451
[26] Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities
Khoury, Paneez
Roufosse, Florence
Kuang, Fei Li
Ackerman, Steven J.
Akuthota, Praveen
Bochner, Bruce S.
Johansson, Mats W.
Mathur, Sameer K.
Ogbogu, Princess U.
Spencer, Lisa A.
Wechsler, Michael E.
Zimmermann, Nives
Klion, Amy D.
JOURNAL OF LEUKOCYTE BIOLOGY, 2024, 116 (02) : 307 - 320
[27] Chemokines in gastrointestinal disorders
Gijsbers, K
Geboes, K
Van Damme, J
CURRENT DRUG TARGETS, 2006, 7 (01) : 47 - 64
[28] Novel Targeted Therapies for Eosinophil-Associated Diseases and Allergy
Radonjic-Hoesli, Susanne
Valent, Peter
Klion, Amy D.
Wechsler, Michael E.
Simon, Hans-Uwe
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55, 2015, 55 : 633 - 656
[29] Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
Pavord, Ian D.
Chapman, Kenneth R.
Bafadhel, Mona
Sciurba, Frank C.
Bradford, Eric S.
Harris, Stephanie Schweiker
Mayer, Bhabita
Rubin, David B.
Yancey, Steven W.
Paggiaro, Pierluigi
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 1755 - 1770
[30] T helper-2 immunity regulates bronchial hyperresponsiveness in eosinophil-associated gastrointestinal disease in mice
Forbes, E
Smart, VE
D'Aprile, A
Henry, P
Yang, M
Matthaei, KI
Rothenberg, ME
Foster, PS
Hogan, SP
GASTROENTEROLOGY, 2004, 127 (01) : 105 - 118

← 1 2 3 4 5 →